- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
ReWalk Robotics Ltd (LFWD)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/12/2025: LFWD (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $5.17
1 Year Target Price $5.17
| 1 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -46.58% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 12.38M USD | Price to earnings Ratio - | 1Y Target Price 5.17 |
Price to earnings Ratio - | 1Y Target Price 5.17 | ||
Volume (30-day avg) 3 | Beta 0.01 | 52 Weeks Range 0.50 - 4.00 | Updated Date 12/14/2025 |
52 Weeks Range 0.50 - 4.00 | Updated Date 12/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.91 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Earnings Date
Report Date 2025-11-18 | When - | Estimate -0.205 | Actual -0.19 |
Profitability
Profit Margin -121.82% | Operating Margin (TTM) -50.69% |
Management Effectiveness
Return on Assets (TTM) -32.29% | Return on Equity (TTM) -127.95% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 10662227 | Price to Sales(TTM) 0.51 |
Enterprise Value 10662227 | Price to Sales(TTM) 0.51 | ||
Enterprise Value to Revenue 0.44 | Enterprise Value to EBITDA 1.04 | Shares Outstanding 18293776 | Shares Floating 17469524 |
Shares Outstanding 18293776 | Shares Floating 17469524 | ||
Percent Insiders 1.86 | Percent Institutions 4.65 |
About ReWalk Robotics Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2014-09-12 | President, CEO & Director Mr. William Mark Grant | ||
Sector Healthcare | Industry Medical Devices | Full time employees 80 | Website https://golifeward.com |
Full time employees 80 | Website https://golifeward.com | ||
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

